| Product NDC: | 66288-2225 |
| Proprietary Name: | Cefuroxime Sodium |
| Non Proprietary Name: | Cefuroxime Sodium |
| Active Ingredient(s): | 225 g/1 & nbsp; Cefuroxime Sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 66288-2225 |
| Labeler Name: | Samson Medical Technologies, L.L.C. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065251 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100201 |
| Package NDC: | 66288-2225-1 |
| Package Description: | 1 INJECTION, POWDER, FOR SOLUTION in 1 BAG (66288-2225-1) |
| NDC Code | 66288-2225-1 |
| Proprietary Name | Cefuroxime Sodium |
| Package Description | 1 INJECTION, POWDER, FOR SOLUTION in 1 BAG (66288-2225-1) |
| Product NDC | 66288-2225 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cefuroxime Sodium |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100201 |
| Marketing Category Name | ANDA |
| Labeler Name | Samson Medical Technologies, L.L.C. |
| Substance Name | CEFUROXIME SODIUM |
| Strength Number | 225 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |